Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer.

Obesity, an established risk factor for endometrial cancer (EC), is also associated to increased risks of intraoperative and postoperative complications. A reliable tool to identify patients at low risk for lymph node (LN) metastasis may allow minimizing the surgical staging and omit lymphadenectomy in obese patients. To identify molecular biomarkers that could predict LN involvement in obese patients with EC we performed gene expression analysis in 549 EC patients using publicly available transcriptomic datasets. Patients were filtrated according to cancer subtype, weight (>30 kg/m2) and LN status. While in the LN+ group, NEB, ANK1, AMIGO2, LZTS1, FKBP5, CHGA, USP32P1, CLIC6, CEMIP, HMCN1 and TNFRSF10C genes were highly expressed; in the LN- group CXCL14, FCN1, EPHX3, DDX11L2, TMEM254, RNF207, LTK, RPL36A, HGAL, B4GALNT4, KLRG1 genes were up-regulated. As a second step, we investigated these genes in our patient cohort of 35 patients (15 LN+ and 20 LN-) and found the same correlation with the in-silico analysis. In addition, immunohistochemical expression was confirmed in the tumor tissue. Altogether, our findings propose a novel panel of genes able to predict LN involvement in obese patients with endometrial cancer. Copyright © 2021 López-Ozuna, Kogan, Hachim, Matanes, Hachim, Mitric, Kiow, Lau, Salvador, Yasmeen and Gotlieb.

Citation

Vanessa M López-Ozuna, Liron Kogan, Mahmood Y Hachim, Emad Matanes, Ibrahim Y Hachim, Cristina Mitric, Lauren Liu Chen Kiow, Susie Lau, Shannon Salvador, Amber Yasmeen, Walter H Gotlieb. Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer. Frontiers in oncology. 2021;11:695404

PMID: 34307159

search → result